Does ADALIMUMAB Cause Transfusion? 264 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Transfusion have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
264
Reports of Transfusion with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
4
Deaths
127
Hospitalizations
How Dangerous Is Transfusion From ADALIMUMAB?
Of the 264 reports, 4 (1.5%) resulted in death, 127 (48.1%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Transfusion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 264 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Transfusion?
MACITENTAN (858)
VENETOCLAX (793)
APIXABAN (561)
ECULIZUMAB (454)
WARFARIN (377)
SELEXIPAG (289)
AMBRISENTAN (244)
CEDAZURIDINE\DECITABINE (229)
EPOPROSTENOL (225)
IBRUTINIB (212)
Which ADALIMUMAB Alternatives Have Lower Transfusion Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB